170 related articles for article (PubMed ID: 6416946)
1. Hodgkin's disease in a patient after treatment for angioimmunoblastic lymphadenopathy.
Melato M; Falconieri G; Giammarini Barsanti A; Mottola A
Haematologica; 1983; 68(5):675-9. PubMed ID: 6416946
[No Abstract] [Full Text] [Related]
2. [Drug therapy of Hodgkin's disease].
Gallmeier WM; Bruntsch U
Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
[No Abstract] [Full Text] [Related]
3. [A case of angioimmunoblastic lymphadenopathy with dysproteinemia].
Lazza M; Ramella G; Cianferoni MF; Rognoni M; Bevilacqua M
Minerva Med; 1982 Nov; 73(43):3049-52. PubMed ID: 6897286
[TBL] [Abstract][Full Text] [Related]
4. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
5. Splenectomy effects on chemotherapy in Hodgkin's disease.
Panettiere F; Coltman CA
Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035
[No Abstract] [Full Text] [Related]
6. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
[No Abstract] [Full Text] [Related]
7. [Experience with the management of patients with therapy-resistant Hodgkin's disease].
Berényi E; Szegedi G
Orv Hetil; 1984 Nov; 125(45):2737-40, 2743. PubMed ID: 6548560
[No Abstract] [Full Text] [Related]
8. Status and perspectives in chemotherapy of Hodgkin's disease.
Frei E
Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
[No Abstract] [Full Text] [Related]
9. [Combined chemotherapy in Hodgkin's disease].
Somers R; Haanen C; Hart AA; Kroese WF; Sizoo W; Wagener DJ
Ned Tijdschr Geneeskd; 1976 Jun; 120(24):1038-43. PubMed ID: 1272447
[No Abstract] [Full Text] [Related]
10. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Neumann E
Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Fiacchini M; Lauria F; Mazza P; Tura S
Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
[No Abstract] [Full Text] [Related]
12. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
13. The treatment of Hodgkin's disease.
Fairley GH
Trans Med Soc Lond; 1972; 88():61-71. PubMed ID: 4665820
[No Abstract] [Full Text] [Related]
14. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
15. Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy.
Kemona H; Wysocka J; Prokopowicz J; Kiluk S
Neoplasma; 1987; 34(1):107-13. PubMed ID: 3561600
[TBL] [Abstract][Full Text] [Related]
16. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
Andrieu JM; Colonna P
J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
[No Abstract] [Full Text] [Related]
17. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
[TBL] [Abstract][Full Text] [Related]
18. Single-agent therapy for Hodgkin's disease.
Carter SK; Livingston RB
Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
[No Abstract] [Full Text] [Related]
19. [Recurrent paralysis induced by vincristine during the treatment of Hodgkin's disease].
Chauffert B; Lorcerie B; André F; Besancenot JF; Martin F
Presse Med; 1989 Nov; 18(39):1930-1. PubMed ID: 2531872
[No Abstract] [Full Text] [Related]
20. [Treatment of lymphogranulomatosis].
Baĭsogolov GD
Med Radiol (Mosk); 1982 Sep; 27(9):83-9. PubMed ID: 6897278
[No Abstract] [Full Text] [Related]
[Next] [New Search]